Arovella Therapeutics Ltd. appointed Dr. Elizabeth Stoner, M.S. M.D., as an independent Non-Executive Director. Dr. Stoner, based in Boston, has over 30 years' experience in the life-sciences sector, spanning early- stage research, drug development and venture investing. She is currently Executive Partner at MPM Capital, a leading US healthcare investment firm, with over two decades of experience founding and investing in life-sciences companies that seek to translate scientific innovations into cures for major diseases. Dr. Stoner currently serves on the board of Triplett Therapeutics. She is also a member of the Albert Einstein College of Medicine Board of Governors, and the Weill Cornell Medical College Clinical and Translational Science Center External Advisory Board.